Press release
Kelso Pharma announces first product launch
January 30, 2023Business Services
30th January 2023: Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the …
Pharmacists say England is not yet unlocking potential of self-care, with 77% backing the idea of a National Self-Care Strategy
January 30, 2023Business Services
London, 30 January 2023. Today, a new report by Sanofi, an innovative global healthcare company, calls on the Government to …
t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells
January 26, 2023Business Services
26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it …
Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease
January 26, 2023Business Services
26 January 2023 Galway, Ireland – Orbsen Therapeutics Limited (“Orbsen”), a global leader in stromal cell immunotherapies, today announces encouraging …
First CAR T-cell therapy recommended for routine use on the NHS in England
January 26, 2023Business Services
26th JANUARY 2023, LONDON, UK – Gilead Sciences Ltd. and Kite, a Gilead company, today announced that the National Institute …
Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases
January 26, 2023Business Services
Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …
Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition
January 26, 2023Business Services
MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK …
US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections
January 25, 2023Business Services
Brighton, United Kingdom – 25 January 2023 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on …
Vertex and CRISPR Therapeutics Announce EMA Marketing Authorization Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa
January 25, 2023Business Services
LONDON, UK and ZUG, Switzerland, January 25, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that …
STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference
January 25, 2023Business Services
25 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …
Scancell Holdings plc: Interim Results for the 6 months ended 31 October 2022
January 25, 2023Business Services
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces …
Sosei Heptares Webinar Presentation for FY2022 Financial Results
January 25, 2023Business Services
Tokyo, Japan and Cambridge, UK, 25 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation
January 24, 2023Business Services
London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …
UK seeing exodus of R&D activity, research reveals
January 24, 2023Business Services
London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …
Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence
January 24, 2023Business Services
London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
